SUPN   $49.25  3.12% Market Closed After Close 49.25 0.0

Supernus Pharmaceuticals, Inc.

EMA (20): 2026-03-12 the price crossed down the moving average line and demonstrates a strong downside trend.

EMA (50): 2026-03-12 the price crossed down the moving average line and formed a short-term downside trend.

EMA (100): 2026-03-18 the price crossed down the moving average line and formed a short-term downside trend.

RSI: RSI indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: entrance to the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: down-crossing the middle level.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: main and signal line crossing.

Trend Type up and flat
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -5.35%
EMA (20) date of signal March 12, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -5.35%
EMA (50) date of signal March 12, 2026, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -3.10%
EMA (100) date of signal March 18, 2026, 3 a.m.
RSI Signals bearish recovery
RSI (14) Yield -3.10%
RSI (14) date of signal March 18, 2026, 3 a.m.
MACD Signals bearish
MACD Yield -6.02%
MACD date of signal March 17, 2026, 3 a.m.
Stochastic Signals bearish recovery
Stochastic Yield 0.0
Stochastic date of signal March 20, 2026, 3 a.m.
Updated March 22, 2026, 11:01 p.m.